Drug intelligence / Profile preview

N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamide

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a synthetic small molecule belonging to the phenylpiperidine class. It is identified by several research and chemical database codes (CHEMBL258040, BDBM50237845, DB07220). The molecular formula is C23H27N5O3S and its structure features an indazole core linked to a piperidinophenyl acetamide moiety with an isothiazolidine dioxide substituent. There are no approved medical indications or clinical trial data available for this compound; it appears to be an experimental molecule with no established mechanism of action or known biological target in the public domain[1][7][8]. No information on pharmacological activity or therapeutic use has been published.

Other names: N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamideN-[5-(1,1-dioxo-isothiazolidinyl)-1H-indazol–3–yl]–2–[4–(piperidin–1–yl)phenyl]acetamide

Beyond the preview

Go deeper on N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[5-(1,1-dioxidoisothiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-piperidin-1-ylphenyl)acetamide.

Explore the full profile